NORDICCELL ApS: Financial statements 2020
CVR: 27293972
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 8,598,908 and a net result of DKK 2,947,229 compared with DKK 886,352 the year before. That is an increase of 26.4% compared with the year before. Equity in the 2020 report amounted to DKK 4,326,658. The solvency ratio was 37.1%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 8,598,908
- Profit/Loss
- DKK 2,947,229
- Equity
- DKK 4,326,658
- Total Assets
- DKK 11,663,435
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 8.6 mio. | 2.9 mio. | 4.3 mio. | 9 |
| 2019 | - | 6.8 mio. | 886 t. | 2.3 mio. | 10 |
| 2018 | - | 6.5 mio. | 1.5 mio. | 2.9 mio. | 10 |
| 2017 | - | 7.1 mio. | 2.6 mio. | 4 mio. | 9 |
| 2016 | - | 5.6 mio. | 2 mio. | 1.3 mio. | 8 |
Official annual report
How creditworthy is NORDICCELL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.